Blinding strategies in the conduct and reporting of a randomized placebo-controlled device trial

Clinical Trials

Volumn 11, Issue 5, 2014, Pages 547-552

  Houweling, Adrielle H ^a   Shapiro, Stan ^a,b   Cohen, Jacqueline M ^a,b   Kahn, Susan R ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Blinding; Deep vein thrombosis; Device trial; Elastic compression stockings; Post thrombotic syndrome; Randomized controlled trial

Indexed keywords

ADULT; ARTICLE; BLINDING PROCEDURE; COMPRESSION STOCKING; DEEP VEIN THROMBOSIS; FEMALE; FOLLOW UP; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; POSTTHROMBOSIS SYNDROME; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); AGED; CLINICAL TRIAL; COMPLICATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; MULTICENTER STUDY; PLACEBO EFFECT; POSTTHROMBOTIC SYNDROME; RANDOMIZED CONTROLLED TRIAL; STANDARDS; VENOUS THROMBOSIS;

ADULT; AGED; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PLACEBO EFFECT; POSTTHROMBOTIC SYNDROME; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STOCKINGS, COMPRESSION; VENOUS THROMBOSIS;

EID: 84924907664     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774514535999     Document Type: Article

References (21)

1. Boutron I, Moher D, Altman DG, et al.; CONSORT Group. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 2008; 148: 295-309.
2. Boutron I, Guittet L, Estellat C, et al. Reporting methods of blinding in randomized trials assessing nonpharmacological treatments. PLoS Med 2007; 4: e61.
3. Kolahi J, Bang H and Park J. Towards a proposal for assessment of blinding success in clinical trials: up-to-date review. Community Dent Oral Epidemiol 2009; 37: 477-484.
4. Hró bjartsson A, Forfang E, Haahr MT, et al. Blinded trials taken to the test: an analysis of randomized clinical trials that report tests for the success of blinding. Int J Epidemiol 2007; 36: 654-663.
5. Fergusson D, Glass KC, Waring D, et al. Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials. BMJ 2004; 328: 432.
6. Schulz KF and Grimes DA. Blinding in randomised trials: hiding who got what. Lancet 2002; 359: 696-700.
7. Boutron I, Estellat C, Guittet L, et al. Methods of blinding in reports of randomized controlled trials assessing pharmacologic treatments: a systematic review. PLoS Med 2006; 3: e425.
8. Park J, Bang H and Canette I. Blinding in clinical trials, time to do it better. Complement Ther Med 2008; 16: 121-123.
9. Guanella R, Ducruet T, Johri M, et al. Economic burden and cost determinants of deep vein thrombosis during 2 years following diagnosis: a prospective evaluation. J Thromb Haemost 2011; 9: 2397-2405.
10. Ashrani AA and Heit JA. Incidence and cost burden of post-thrombotic syndrome. J Thromb Thrombolysis 2009; 28: 465-476.
11. Kahn SR and Ginsberg JS. The post-thrombotic syndrome: current knowledge, controversies, and directions for future research. Blood Rev 2002; 16: 155-165.
12. Prandoni P, Lensing AWA, Cogo A, et al. The Longterm clinical course of acute deep venous thrombosis. Ann Intern Med 1996; 125: 1-7.
13. Brandjes DPM, Buller HR, Heijboer H, et al. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 1997; 349: 759-762.
14. Prandoni P, Lensing AWA, Prins MH, et al. Below-knee elastic compression stockings to prevent the postthrombotic syndrome: a randomized, controlled trial. Ann Intern Med 2004; 141: 249-256.
15. Kahn SR, Shapiro S, Wells PS, et al. Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial. Lancet. 2014; 383(9920): 880-888.
16. Kahn SR, Shbaklo H, Shapiro S, et al. Effectiveness of compression stockings to prevent the post-thrombotic syndrome (the SOX trial and Bio-SOX biomarker substudy): a randomized controlled trial. BMC Cardiovasc Disord 2007; 7: 21.
17. James KE, Bloch DA, Lee KK, et al. An index for assessing blindness in a multi-centre clinical trial: disulfiram for alcohol cessation-a VA cooperative study. Stat Med 1996; 15: 1421-1434.
18. Bang H, Ni L and Davis CE. Assessment of blinding in clinical trials. Control Clin Trials 2004; 25: 143-156.
19. Moroz A, Freed B, Tiedemann L, et al. Blinding measured: a systematic review of randomized controlled trials of acupuncture. Evid Based Complement Alternat Med 2013; 2013: 708251.
20. Kahn SR, Shbaklo H, Lamping DL, et al. Determinants of health-related quality of life during the 2 years following deep vein thrombosis. J Thromb Haemost 2008; 6: 1105-1112.
21. Sackett DL. Commentary: measuring the success of blinding in RCTs: don't, must, can't or needn't? Int J Epidemiol 2007; 36: 664-665.